Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Culine

Showing results (121-130 of 185) with videos related to

Pageof 19
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 7, 2010
[Recommendations Onco-Urology 2010: Malignancies of the penis]J Rigaud, C Avancès, P Camparo, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 27, 2012
[Prostate cancer, androgenic suppression and associated conditions. Practical refinement by a panel of multidisciplinary experts for patient integral management]P Coloby, L Boccon-Gibod, C Coulange, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2008
An open phase II trial of gemcitabine, oxaliplatin and vinorelbine combination as first-line therapy in advanced non-small cell lung cancer patientsJ Trédaniel, C Becht, M Bekradda, et al.
Gynecologic Oncology|July 1, 1994
A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovaryS Culine, J Kattan, C Lhomme, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2017
Q-TWiST analysis of patients with metastatic castrate naive prostate cancer treated by androgen deprivation therapy with or without docetaxel in the randomised phase III GETUG-AFU 15 trialP Marino, P Sfumato, F Joly, et al.
Urology|November 1, 1993
Penile cancer chemotherapy: twelve years' experience at Institut Gustave-RoussyJ Kattan, S Culine, J P Droz, et al.
Bulletin Du Cancer|April 10, 2009
[Prognostic factors in renal cell carcinoma]N Letang, L Cabaniols, D Pouessel, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 1, 2005
[Concomitant use of radiotherapy and gemcitabine: preclinical findings and clinical practice]D Azria, M Coelho, C Larbouret, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2010
[Update on the use of estramustin in metastatic prostate cancer]S Culine, L Drouet, J-C Eymard, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 29, 2011
[Penile cancer in 2010: update from the Oncology Committee of the French Association of Urology: external genital organs group (CCAFU-OGE)]I Souillac, C Avances, P Camparo, et al.
Pageof 19

Showing results (121-130 of 185) with videos related to

Sort By:
Pageof 19
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 7, 2010
[Recommendations Onco-Urology 2010: Malignancies of the penis]J Rigaud, C Avancès, P Camparo, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 27, 2012
[Prostate cancer, androgenic suppression and associated conditions. Practical refinement by a panel of multidisciplinary experts for patient integral management]P Coloby, L Boccon-Gibod, C Coulange, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2008
An open phase II trial of gemcitabine, oxaliplatin and vinorelbine combination as first-line therapy in advanced non-small cell lung cancer patientsJ Trédaniel, C Becht, M Bekradda, et al.
Gynecologic Oncology|July 1, 1994
A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovaryS Culine, J Kattan, C Lhomme, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2017
Q-TWiST analysis of patients with metastatic castrate naive prostate cancer treated by androgen deprivation therapy with or without docetaxel in the randomised phase III GETUG-AFU 15 trialP Marino, P Sfumato, F Joly, et al.
Urology|November 1, 1993
Penile cancer chemotherapy: twelve years' experience at Institut Gustave-RoussyJ Kattan, S Culine, J P Droz, et al.
Bulletin Du Cancer|April 10, 2009
[Prognostic factors in renal cell carcinoma]N Letang, L Cabaniols, D Pouessel, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 1, 2005
[Concomitant use of radiotherapy and gemcitabine: preclinical findings and clinical practice]D Azria, M Coelho, C Larbouret, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2010
[Update on the use of estramustin in metastatic prostate cancer]S Culine, L Drouet, J-C Eymard, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 29, 2011
[Penile cancer in 2010: update from the Oncology Committee of the French Association of Urology: external genital organs group (CCAFU-OGE)]I Souillac, C Avances, P Camparo, et al.
Pageof 19